The clonoSEQ® Watch Registry
Updated: Feb 10
The clonoSEQ® Watch Registry
Real World Observational Study Using clonoSEQ® Next Generation Sequencing in Hematologic Malignancies: The 'Watch' Registry
l
This is a prospective, multicenter, observational study of adult patients with a diagnosis of acute lymphoblastic leukemia (ALL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), or non-Hodgkin lymphoma (NHL). This study will enroll up to 528 patients in up to 50 sites in the United States and collect data with regard to use of the clonoSEQ MRD assay in the management of lymphoid malignancies.
Diagnostic Test
Sponsor
ClinicalTrials.gov Identifier: NCT04545333
Official Title: Real World Observational Study Using clonoSEQ® Next Generation Sequencing in Hematologic Malignancies: The 'Watch' Registry
First Posted: September 11, 2020
Click here for details on ClinicalTrials.gov
- Multiple Locations
Locations
United States, California
United States, Colorado
United States, District of Columbia
United States, Florida
United States, Illinois
United States, Louisiana
United States, Maryland
United States, Missouri
United States, North Carolina
United States, Oregon
United States, Pennsylvania
United States, South Carolina
United States, Washington